$INFI News Article - Infinity Pharmaceuticals Presents Data

New Post Public Reply Private Reply Replies (0) Message Board Keep
whytestocks
414
$INFI News Article - Infinity Pharmaceuticals Presents Data from Randomized, Placebo-Controlled, Phase 2 MARIO-275 Trial of Eganelisib and Nivolumab in Advanced Urothelial Cancer at ASCO Genitourinary Cancers Symposium https://marketwirenews.com/news-releases/infi...60486.html

Infinity Pharmaceuticals Inc. (INFIQ) Stock Research Links

INFIQ Board Company Profile Buy Rating Time & Sales News Filings Financials
My Twitter: WhyteStocks